Animalcare logo

ANCR - Animalcare Share Price

170p 0.0  0.0%

Last Trade - 04/06/20

Sector
Healthcare
Size
Small Cap
Market Cap £102.1m
Enterprise Value £119.9m
Revenue £71.1m
Position in Universe 914th / 1817
Bullish
Bearish
Unlock ANCR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Animalcare Group Plc revenues decreased 2% to £71.1M. Net loss before extraordinary items increased from £220K to £1.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Total Amort of Intangibles-excl Goodwill increase from £513K to £1.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ANCR Revenue Unlock ANCR Revenue

Net Income

ANCR Net Income Unlock ANCR Revenue

Normalised EPS

ANCR Normalised EPS Unlock ANCR Revenue

PE Ratio Range

ANCR PE Ratio Range Unlock ANCR Revenue

Dividend Yield Range

ANCR Dividend Yield Range Unlock ANCR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANCR EPS Forecasts Unlock ANCR Revenue
Profile Summary

Animalcare Group plc is a United Kingdom-based sales, marketing and product development company. The Company is principally engaged in the development, sale and distribution of licensed veterinary pharmaceuticals and identification products and services to companion animal veterinary markets. The Company develops and sells goods and services to veterinary professionals principally for use in companion animals, operating through the United Kingdom wholesalers and distribution and development partners in markets in Western Europe. The Company's product portfolio is divided into three product groups: pharmaceuticals (Licensed Veterinary Medicines); pet microchips (Companion Animal Identification), and consumable items (Animal Welfare Products). Animalcare Ltd is the Company's subsidiary. It has operations in the United Kingdom, Europe and Rest of World.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated June 14, 1972
Public Since January 15, 2008
No. of Shareholders: n/a
No. of Employees: 279
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 60,057,161
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ANCR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ANCR
Upcoming Events for ANCR
Wednesday 24th June, 2020 Estimate
Animalcare Group PLC Annual Shareholders Meeting
Frequently Asked Questions for Animalcare
What is the Animalcare share price?

As of 04/06/20, shares in Animalcare are trading at 170p, giving the company a market capitalisation of £102.1m. This share price information is delayed by 15 minutes.

How has the Animalcare share price performed this year?

Shares in Animalcare are currently trading at 170p and the price has moved by 6.25% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Animalcare price has moved by 22.01% over the past year.

What are the analyst and broker recommendations for Animalcare?

Of the analysts with advisory recommendations for Animalcare, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Animalcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Animalcare next release its financial results?

Animalcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Animalcare dividend yield?

Animalcare does not currently pay a dividend.

Does Animalcare pay a dividend?

Animalcare does not currently pay a dividend.

When does Animalcare next pay dividends?

Animalcare does not currently pay a dividend.

How do I buy Animalcare shares?

To buy shares in Animalcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Animalcare?

Shares in Animalcare are currently trading at 170p, giving the company a market capitalisation of £102.1m.

Where are Animalcare shares listed? Where are Animalcare shares listed?

Here are the trading details for Animalcare:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: ANCR
What kind of share is Animalcare?

Based on an overall assessment of its quality, value and momentum, Animalcare is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Animalcare share price forecast 2020?

Shares in Animalcare are currently priced at 170p. At that level they are trading at 17.65% discount to the analyst consensus target price of 206.44.

Analysts covering Animalcare currently have a consensus Earnings Per Share (EPS) forecast of 0.1175 for the next financial year.

How can I tell whether the Animalcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Animalcare. Over the past six months, the relative strength of its shares against the market has been 16.79%. At the current price of 170p, shares in Animalcare are trading at -0.38% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Animalcare PE Ratio?

The Animalcare PE ratio based on its reported earnings over the past 12 months is 24.96. The shares are currently trading at 170p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Animalcare?

Animalcare's management team is headed by:

Jennifer Winter - CEO
Marc Coucke - NED
Nick Downshire - NID
Chris Brewster - CFO
Jan Boone - NEC
Chris Cardon - NED
Edwin Torr - NID
Who are the major shareholders of Animalcare?

Here are the top five shareholders of Animalcare based on the size of their shareholding:

Coucke (Marc) Individual Investor
Percentage owned: 23.07% (13.9m shares)
Cardon (Chris) Individual Investor
Percentage owned: 23.07% (13.9m shares)
Liontrust Asset Management PLC Investment Advisor/Hedge Fund
Percentage owned: 11.19% (6.72m shares)
Liontrust UK Smaller Companies Fund Mutual Fund
Percentage owned: 9.88% (5.94m shares)
Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 5.88% (3.53m shares)
Similar to ANCR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.